CEACAM5 and colorectal carcinoma: Although this suggests an association between elevated CEA levels and worse prognosis in patients with stage II CRC, there is currently insufficient evidence and guidelines supporting the use of elevated CEA levels as a definitive indication or high-risk factor for adjuvant therapy in stage II CRC.